3/18/2024

Mometasone Furoate Oral Inhalers

Products Affected - Description

- Asmanex HFA inhalation aerosol, Organon, 100 mcg/actuation (120 metered actuations), 13 grams, metered dose inhaler, 1 count, NDC 78206-0112-01
- Asmanex HFA inhalation aerosol, Organon, 200 mcg/actuation (120 metered actuations), 13 grams, metered dose inhaler, 1 count, NDC 78206-0113-01
- Asmanex HFA inhalation aerosol, Organon, 50 mcg/actuation (120 metered actuations), 13 grams, metered dose inhaler, 1 count, NDC 78206-0111-01
- Asmanex Twisthaler inhalation powder, Organon, 110 mcg/actuation, inhaler, 30 count, NDC 78206-0115-01
- Asmanex Twisthaler inhalation powder, Organon, 220 mcg/actuation, inhaler, 14 count, NDC 78206-0114-03
- Asmanex Twisthaler inhalation powder, Organon, 220 mcg/actuation, inhaler, 30 count, NDC 78206-0114-04
- Asmanex Twisthaler inhalation powder, Organon, 220 mcg/actuation, inhaler, 60 count, NDC 78206-0114-02
- Asmanex Twisthaler inhalation powder, Organon, 220 mcg/actuation, inhaler, 120 count, NDC 78206-0114-01

Reason for the Shortage

- Organon states customer demand for Asmanex HFA and Asmanex Twisthaler has increased due to the discontinuation of Flovent HFA and Flovent Diskus in late-2023.

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- Organon is releasing Asmanex HFA inhalers regularly and wholesalers are allocating product.
- Organon has Asmanex Twisthalers 220 mcg in 14 and 30 count on back order and the company cannot estimate a release date. Organon is regularly releasing all other presentations and wholesalers are allocating product.

Updated

Updated March 18, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 18, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.